News & Resources
Category: Product Liability - Page 4
In late June 2012, a FDA Advisory Panel (consisting of orthopedic surgeons, medical experts, industry representatives, and patient advocates) convened a two day hearing to publically discuss safety data on metal-on-metal hip implants.
Ethicon Inc., a wholly owned subsidiary of Johnson & Johnson, has decided to cease marketing and producing four types of vaginal mesh implants.
The U.S. Supreme Court ruling in June of 2011 in the case of Pliva v. Mensing had devastating consequences for a vast number of consumers injured by generic drugs.
The Government Accountability Office (GAO) has compiled a report looking at the steps the FDA has been taking to improve communication between the internal offices of the FDA, in an effort to protect the public from dangerous drugs released on the U.S. market.
The American Recovery and Reinvestment Act allocated $1.1 billion dollars to coordinate research and guide investments in comparative research funded by the Act.